How has UroGen Pharma's amortization of debt discount premium changed year-over-year?

UroGen Pharma's amortization of debt discount premium increased by 427.8% year-over-year, from $374K to $1.97M.

UroGen Pharma URGN Amortization Of Debt Discount Premium

Amortization Of Debt Discount Premium at other companies

NXP SemiconductorsNXPI

$1M0.0%

Microchip TechnologyMCHP

$7.6M-42.4%

Lumentum Holdings Inc.LITE

$1.1M+37.5%

ON SemiconductorON

$2.9M0.0%

Devon EnergyDVN

$4M-33.3%

Extra Space StorageEXR

$12.56M+11.0%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's amortization of debt discount premium.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's amortization of debt discount premium?: UroGen Pharma (URGN) reported amortization of debt discount premium of $1.97M in Q1 2026.
How has UroGen Pharma's amortization of debt discount premium changed year-over-year?: UroGen Pharma's amortization of debt discount premium increased by 427.8% year-over-year, from $374K to $1.97M.